Clinical Trials
1.5k
Active:99
Completed:850
Trial Phases
6 Phases
Early Phase 1:24
Phase 1:101
Phase 2:146
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1107 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
702 (63.4%)Phase 2
146 (13.2%)Phase 1
101 (9.1%)Phase 4
94 (8.5%)Phase 3
40 (3.6%)Early Phase 1
24 (2.2%)Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome
Not Applicable
Not yet recruiting
- Conditions
- Down SyndromeAutonomic Dysfunction
- First Posted Date
- 2025-11-20
- Last Posted Date
- 2025-11-20
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 200
- Registration Number
- NCT07238465
- Locations
- πΊπΈ
Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Evaluating Mammography Communication Approaches
Not Applicable
Recruiting
- Conditions
- The Focus of This Study is to Identify How Different Approaches to Mammography Communication Affect Skepticism Toward Mammography Evidence
- First Posted Date
- 2025-11-14
- Last Posted Date
- 2025-11-14
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 1900
- Registration Number
- NCT07228234
- Locations
- πΊπΈ
University of Colorado Anschutz, Aurora, Colorado, United States
Dietary Reversal of the Reprometabolic Syndrome
Not Applicable
Active, not recruiting
- Conditions
- Obesity & OverweightInfertility, Female
- First Posted Date
- 2025-11-13
- Last Posted Date
- 2025-11-14
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 30
- Registration Number
- NCT07227766
- Locations
- πΊπΈ
University of Colorado School of Medicine, Aurora, Colorado, United States
Tolerability and Efficacy of CBD Extract for RLS Treatment
Not Applicable
Not yet recruiting
- Conditions
- Restless Leg Syndrome
- Interventions
- Drug: Placecbo
- First Posted Date
- 2025-11-05
- Last Posted Date
- 2025-11-13
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 60
- Registration Number
- NCT07224932
Equol and Vascular Function in Women With Chronic Kidney Disease
Not Applicable
Not yet recruiting
- Conditions
- Chronic Kidney Disease (Stage 3-4)Vascular FunctionCognitive FunctionsCerebrovascular FunctionBlood Pressure
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-09-26
- Last Posted Date
- 2025-09-26
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 74
- Registration Number
- NCT07194590
- Prev
- 1
- 2
- 3
- 4
- 5
- 295
- Next
News
No news found